Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
NEW YORK, NY, Feb. 15, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Image Protect, Inc. (OTC:IMTL) (Imageprotectcorporation.com) (“Image Protect” or the “Company”), a leading player in the digital...
-
NEW YORK, NY, Feb. 14, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire - Image Protect, Inc. (OTC: IMTL) (Imageprotectcorporation.com) (“Image Protect” or the “Company”), is pleased to announce that it...
-
Mikra launches Protect, a new natural immune support product based on Aronia berries and key vitamins, shipping a free trial bottle with our next 500 order
-
Boulder, Colo., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Comprise® solidified its status as a leading communications agency delivering integrated public relations and digital marketing services with the...
-
NEW YORK, NY, Dec. 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire — Image Protect Inc. (OTC:IMTL) (Imageprotectcorporation.com), and its subsidiary Review Control™ Reputation Management, a...
-
Mikra introduces PROTECT, a new natural immune support product based on Aronia berries and key vitamins
-
NEW YORK, NY, Dec. 04, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Image Protect, Inc. (OTC:IMTL) (Imageprotectcorporation.com) (“Image Protect” or the “Company”), a leading player in the online...
-
NEW YORK, NY, Nov. 29, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Image Protect, Inc. (OTC:IMTL) (Imageprotectcorporation.com) (“Image Protect” or the “Company”), is pleased to announce that in the...
-
Image Protect, Inc. to Begin Its Filing Process of Form 211 to Restore Proprietary Quote Eligibility
NEW YORK, NY, Nov. 13, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Image Protect, Inc. (OTC:IMTL) (Imageprotectcorporation.com) (“Image Protect” or the “Company”), is pleased to announce that it is...
-
“The totality of data from the PROTECT study demonstrates FILSPARI is effective, safe and has an important place in the IgAN treatment landscape ..."